Skip to main content
Have a personal or library account? Click to login
Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma Cover

Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma

Open Access
|Jul 2013

References

  1. 1. Tiong LMaddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.2011;1210-24.
  2. 2. Fuchs T, Kachelriess MKalender WA. Technical advances in multi-slice spiral CT.2000;69-73.
  3. 3. Kudo M. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma.2007;S193-9.
  4. 4. Okamoto E, Sato S, Sanchez-Siles AA, Ishine J, Miyake T, Amano Y, et al. Evaluation of virtual CT sonography for enhanced detection of small hepatic nodules: a prospective pilot study.2010;1272-8.
  5. 5. Minami Y, Kudo M, Chung H, Inoue T, Takahashi S, Hatanaka K, et al. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images.2007;111-6.
  6. 6. Kitada T, Murakami T, Kuzushita N, Minamitani K, Nakajo K, Osuga K, et al. Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas.2008;565-71.
  7. 7. Kawasoe H, Eguchi Y, Mizuta T, Yasutake T, Ozaki I, Shimonishi T, et al. Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography.2007;66-72.
  8. 8. Nakai M, Sato M, Sahara S, Takasaka I, Kawai N, Minamiguchi H, et al. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography.2009;62-9.
  9. 9. Numata K, Luo W, Morimoto M, Kondo M, Kunishi Y, Sasaki T, et al. Contrast enhanced ultrasound of hepatocellular carcinoma.2010;68-82.
  10. 10. Minami Y, Kudo M, Hatanaka K, Kitai S, Inoue T, Hagiwara S, et al. Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience.2010;759-64.
  11. 11. Masuzaki R, Shiina S, Tateishi R, Yoshida H, Goto E, Sugioka Y, et al. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.2011;759-64.
  12. 12. Numata K, Morimoto M, Ogura T, Sugimori K, Takebayashi S, Okada M, et al. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography.2008;395-406.
  13. 13. Bruix JSherman M. Management of hepatocellular carcinoma.2005;1208-36.
  14. 14. Kokudo NMakuuchi M. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines.2009;119-21.
  15. 15. Kim YS, Lee WJ, Rhim H, Lim HK, Choi DLee JY. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.2010;758-65.
  16. 16. Kim CK, Choi D, Lim HK, Kim SH, Lee WJ, Kim MJ, et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.2005;66-73.
  17. 17. Lu MD, Yu XL, Li AH, Jiang TA, Chen MH, Zhao BZ, et al. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.2007;1736-49.
  18. 18. Kisaka Y, Hirooka M, Kumagi T, Uehara T, Hiasa Y, Kumano S, et al. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.2006;1241-7.
  19. 19. Kisaka Y, Hirooka M, Koizumi Y, Abe M, Matsuura B, Hiasa Y, et al. Contrastenhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma.2010;138-44.
  20. 20. Landmark KE, Johansen PW, Johnson JA, Johansen B, Uran SSkotland T. Pharmacokinetics of perfluorobutane following intravenous bolus injection and continuous infusion of sonazoid in healthy volunteers and in patients with reduced pulmonary diffusing capacity.2008;494-501.
  21. 21. Hiraoka A, Hirooka M, Koizumi Y, Hidaka S, Uehara T, Ichikawa S, et al. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system.2010;493-7.
DOI: https://doi.org/10.2478/raon-2013-0033 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 224 - 229
Published on: Jul 30, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 Nobuyuki Toshikuni, Hisakazu Shiroeda, Kazuaki Ozaki, Yasuhiro Matsue, Takahiro Minato, Tomoe Nomura, Nobuhiko Hayashi, Tomiyasu Arisawa, Mikihiro Tsutsumi, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.